Name
Alnylam Pharmaceuticals, Inc.
Company Description
About Alnylam Pharmaceuticals Headquartered in Cambridge, MA, Alnylam is leading the translation of RNA interference (RNAi) into a new class of medicines for rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. For more information visit www.alnylam.com.
Website
https://www.alnylam.com/
Product Categories
Therapeutic Medications
Address
675 W. Kendall St.
Cambridge, MA 02142
United States